Luis Calzadilla Bertot

Author

Also Known As

Hiromitsu Kumada, L. CALZADILLA BERTOT, L. Calzadilla Bertot, L. Calzadilla-Bertot, L. Calzadilla‐Bertot, L.C. Bertot, Luis Bertot, Luis C. Bertot, Luis Calzadilla Bertot, Luis Calzadilla-Bertot

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Instituto de Gastroenterología The University of Western Australia Sir Charles Gairdner Hospital Universidad de Sevilla Hospital Universitario Virgen del Rocío

About

Luis Calzadilla Bertot is an author at Instituto de Gastroenterología specializing in medicine, liver physiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	3.3K
2	Health Sciences	5	5	3.2K
3	Diabetes	2	2	111
4	Public Health	1	1	2.3K
5	Epidemiology	1	1	765

Luis Calzadilla Bertot

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Eduardo Vilar‐Gómez, Yadina Martínez-Pérez, Luis Calzadilla Bertot, Gastroenterology ObesityNutritionMetabolic SyndromeMetabolic Associated SteatohepatitisLifestyle Modification	2015	2.3K
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Vincent Wai‐Sun Wong, Gastroenterology Disease ProgressionFatty Liver DiseaseObesityMetabolic SyndromeMetabolic Associated Steatotic Liver Disease	2018	765
Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease Luis Calzadilla Bertot, Gary P. Jeffrey, Bastiaan de Boer, Liver International	2018	118
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease Eduardo Vilar‐Gómez, Alessandra Miranda, B Grá Oramas, Alimentary Pharmacology & Therapeutics	2009	102
Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma Luis Calzadilla Bertot, Gary P. Jeffrey, M. Christopher Wallace, Hepatology Communications	2017	89
The natural history of compensated HCV-related cirrhosis: A prospective long-term study Eduardo Vilar‐Gómez, Yoan Sanchez Rodriguez, Luis Calzadilla Bertot, Journal of Hepatology HepatologyHepatitis CViral HepatitisLiver PhysiologyCompensated Hcv-related Cirrhosis	2012	86
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Vincent Wai‐Sun Wong, Clinical Gastroenterology and Hepatology Diabetes ManagementMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2020	78
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non‐alcoholic steatohepatitis Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Scott L. Friedman, Alimentary Pharmacology & Therapeutics	2016	65
Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy‐proven <scp>NASH</scp> Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Scott L. Friedman, Liver International	2017	62
Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention Eduardo Vilar‐Gómez, Ali Yasells‐Garcia, Yadina Martínez-Pérez, Hepatology	2016	58

Page 1